These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6480448)

  • 1. Mechanism of melphalan crosslink enhancement by misonidazole pretreatment.
    Taylor YC; Sawyer JM; Hsu B; Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1603-7. PubMed ID: 6480448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of chemosensitization by misonidazole in vitro.
    Taylor YC; Bump EA; Brown JM
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):705-8. PubMed ID: 7107402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
    Roizin-Towle LA; Hall EJ
    Br J Cancer; 1981 Aug; 44(2):201-7. PubMed ID: 6168277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing effect of pre-treatment of cells with misonidazole in hypoxia on their response to melphalan in air.
    Smith E; Stratford IJ; Adams GE
    Br J Cancer; 1982 Jul; 46(1):117-26. PubMed ID: 7104191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of sensitization of Chinese hamster ovary cells to melphalan by hypoxic treatment with misonidazole.
    Taylor YC; Evans JW; Brown JM
    Cancer Res; 1983 Jul; 43(7):3175-81. PubMed ID: 6850627
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
    Brown DM; Dionet C; Brown JM
    Radiat Res; 1984 Jan; 97(1):162-70. PubMed ID: 6229806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro.
    Papadopoulou MV; Ji M; Khan SH; Bloomer WD
    Oncol Res; 1999; 11(8):345-57. PubMed ID: 10803738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
    Horsman MR; Evans JW; Brown JM
    Br J Cancer; 1984 Sep; 50(3):305-16. PubMed ID: 6466544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misonidazole chemosensitization of EMT6 spheroids to melphalan.
    Horsman MR; Wood PJ; Brown JM
    Radiother Oncol; 1989 May; 15(1):103-14. PubMed ID: 2748937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective enhancement of hypoxic cell killing by melphalan via thiol depletion: in vitro studies with hypoxic cell sensitizers and buthionine sulfoximine.
    Roizin-Towle L
    J Natl Cancer Inst; 1985 Jan; 74(1):151-7. PubMed ID: 3155814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misonidazole hypoxic cytotoxicity and chemosensitization in two cell lines with different intracellular glutathione levels.
    DeGraff WG; Russo A; Friedman N; Mitchell JB
    Eur J Cancer; 1990 Jan; 26(1):17-20. PubMed ID: 2138473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misonidazole increases the toxicity of BCNU for hypoxic cells.
    Tannock I; Guttman P
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):663-6. PubMed ID: 7107395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
    McNally NJ; Hinchliffe M; de Ronde J
    Br J Cancer; 1983 Aug; 48(2):271-8. PubMed ID: 6882665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.
    Murray D; Meyn RE
    Br J Cancer; 1983 Feb; 47(2):195-203. PubMed ID: 6824567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization by hypoxic pretreatment with misonidazole: an interaction of damage at the DNA level.
    Taylor YC; Evans JW; Brown JM
    Radiat Res; 1987 Mar; 109(3):364-73. PubMed ID: 3550868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosensitization: do thiols matter?
    Roizin-Towle L; Hall EJ; Costello T; Biaglow JE; Varnes ME
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1599-602. PubMed ID: 6480447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cytotoxicity of melphalan by prolonged exposure to nitroimidazoles: the role of endogenous thiols.
    Roizin-Towle L; Hall EJ; Flynn M; Biaglow JE; Varnes ME
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):757-60. PubMed ID: 7107410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity.
    Hirst DG; Brown JM
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):639-42. PubMed ID: 7107389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC; Denekamp J; Minchinton AI
    Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
    Brown JM; Hirst DG
    Br J Cancer; 1982 May; 45(5):700-8. PubMed ID: 7082556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.